| Literature DB >> 23930342 |
Saval Khanal1, Mohamed Izham B Mohamed Ibrahim, Pathiyil Ravi Shankar, Subish Palaian, Pranaya Mishra.
Abstract
Academic detailing is rarely practised in developing countries. A randomized control trial on healthcare service was conducted to evaluate the impact of academic detailing programme on the adherence of primary healthcare providers in Banke district, Nepal, to childhood diarrhoea treatment guidelines recommended by World Health Organization/United Nations Children's Fund (WHO/UNICEF). The participants (N=209) were systematically divided into control and intervention groups. Four different academic detailing sessions on childhood diarrhoea management were given to participants in the intervention group. At baseline, 6% of the participants in the control and 8.3% in the intervention group were adhering to the treatment guidelines which significantly (p < 0.05) increased among participants in the intervention (65.1%) than in the control group (16.0%) at the first follow-up. At the second follow-up, 69.7% of participants in the intervention group were adhering to the guidelines, which was significantly (p < 0.05) greater than those in the control group (19.0%). Data also showed significant improvement in prescribing pattern of the participants in the intervention group compared to the control group. Therefore, academic detailing can be used for promoting adherence to treatment guidelines in developing countries, like Nepal.Entities:
Mesh:
Year: 2013 PMID: 23930342 PMCID: PMC3702345 DOI: 10.3329/jhpn.v31i2.16388
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Figure 1.Sampling method (N=209)
Figure 2.Flowchart showing operational modality of research
Demographic characteristics of participants
| Characteristics | Number of participants | ||
|---|---|---|---|
| Control group (n=100) | Intervention group (n=109) | p value | |
| Gender | |||
| Male | 66 | 72 | 0.993 |
| Female | 34 | 37 | |
| Age | |||
| 21-<31 years | 49 | 45 | 0.572 |
| 31-<41 years | 38 | 46 | |
| 41-50 years | 11 | 13 | |
| >50 years | 2 | 3 | |
| Type of organization | |||
| Government | 29 | 34 | 0.730 |
| Private | 71 | 75 | |
| Location | |||
| Urban | 48 | 53 | 0.928 |
| Rural | 52 | 56 | |
| Qualification | |||
| AHW | 44 | 46 | 0.847 |
| CMA | 6 | 6 | |
| HA | 36 | 45 | |
| NM | 14 | 12 | |
| Experience (in years) | |||
| <6 years | 31 | 35 | 0.082 |
| 6-<11 years | 40 | 37 | |
| 11-<16 years | 11 | 22 | |
| 16-20 years | 11 | 8 | |
| >20 years | 7 | 7 | |
| Number of daily patient-visits | |||
| <11 | 6 | 4 | 0.915 |
| 11-20 | 13 | 12 | |
| 21-30 | 35 | 43 | |
| 31-40 | 13 | 17 | |
| 41-50 | 11 | 10 | |
| >50 | 22 | 23 | |
p value (two-sided) was calculated by chi-square test; AHW=Auxiliary health worker; ANM=Auxiliary nurse-midwife CMA=Community medical assistant; HA=Health assistant
Change in prescribing pattern among participants at various phases of the study
| Treatment | Percentage of participants | p value | |
| Control group (n=100) | Intervention group (n=109) | ||
| ORS | |||
| Baseline | 60 | 57.8 | 0.747 |
| First follow-up | 72 | 91.7 | <0.001 |
| Second follow-up | 79 | 95.4 | <0.001 |
| p value | <0.001 | <0.001 | |
| Zinc | |||
| Baseline | 32 | 31.2 | 0.900 |
| First follow-up | 62 | 87.2 | <0.001 |
| Second follow-up | 76 | 96.7 | <0.001 |
| p value | <0.001 | <0.001 | |
| Metronidazole | |||
| Baseline | 56.0 | 54.1 | 0.786 |
| First follow-up | 44.0 | 7.3 | <0.001 |
| Second follow-up | 20.0 | 4.6 | 0.006 |
| p value | 0.014 | <0.001 | |
| Metronidazole+Diloxanide Furoate Combination | |||
| Baseline | 18.0 | 19.2 | 0.814 |
| First follow-up | 20.0 | 6.4 | 0.003 |
| Second follow-up | 18.0 | 6.4 | <0.001 |
| p value | 0.916 | 0.002 | |
| Ciprofloxacin | |||
| Baseline | 6.0 | 1.2 | 0.117 |
| First follow-up | 5.0 | 1.8 | 0.204 |
| Second follow-up | 3.0 | 3.7 | 0.788 |
| p value | 0.248 | 0.115 | |
| Norfloxacin | |||
| Baseline | 3.0 | 1.8 | 0.582 |
| First follow-up | 2.0 | 1.8 | 0.972 |
| Second follow-up | 3.0 | 4.6 | 0.550 |
| p value | 0.346 | 0.114 | |
| Nalidixic acid | |||
| Baseline | 3.0 | 1.8 | 0.582 |
| First follow-up | 5.0 | 1.8 | 0.204 |
| Second follow-up | 5.0 | 1.8 | 0.204 |
| p value | 0.548 | 0.692 | |
| Multivitamins | |||
| Baseline | 19.0 | 19.3 | 0.961 |
| First follow-up | 16.0 | 5.5 | 0.014 |
| Second follow-up | 21.0 | 0659 | 0.002 |
| p value | 0.001 | 6.4 | |
| Enzyme preparations | |||
| Baseline | 11.0 | 12.8 | 0.682 |
| First follow-up | 14.0 | 5.5 | 0.037 |
| Second follow-up | 16.0 | 0.810 | 4.6 |
| p value | 0.046 | 0.032 | |
p value (two-sided) was calculated by chi-square test;
*p value significant at α = 0.05
Change in percentage of participants adhering to the diarrhoea treatment guidelines during different phases of the study
| Phase | Percentage of participants | p value | |
| Control group (n=100) | Intervention group (n=109) | ||
| Baseline | 6.0 | 8.3 | 0.528 |
| First follow-up | 16.0 | 65.1 | <0.001 |
| Second follow-up | 19.0 | 69.7 | <0.001 |
| p value | 0.011 | <0.001 | |
p value (two-sided) was calculated by chi-square test;
*p value significant at α = 0.05
Change in the cost prescribed medicines at various stages of the study
| Phase | Total cost of prescription in Nepalese Rupees | p value | |
| Control group (n=71) | Intervention group (n=75) | ||
| Baseline | |||
| Mean±SD | 65.6±33.0 | 67.1±37.2 | 0.994 |
| Median (IQR) | 68.0 (40-88) | 64.0 (38-89) | |
| First follow-up | |||
| Mean±SD | 64.9±33.0 | 54.7±29.6 | 0.034 |
| Median (IQR) | 65.0 (38-90) | 44.0 (38-66.5) | |
| Second follow-up | |||
| Mean±SD | 65.8±33.0 | 52.6±28.5 | |
| Median (IQR) | 62.0 (38-88) | 44 0 (38-58) | 0.007 |
| p value | 0.894 | 0.098 | |
p value (two-sided) was calculated by Mann-Whitney U-test in horizontal axis and by Friedman test in vertical axis of this table;
*p value significant at α = 0.05